AGI Share Discussion Threads

[hyper al] 16/9/2011 09:05

Fairdeal2008

Good morning.

What's the share distribution like for this one?

[fairdeal2008] 16/9/2011 07:37

Well despite the fact agi350 is seemingly near to completing preclinical work and entering human trials the company is still valued at a third of cast at bank

Cash £6million

Market cap £2million

Just 67 million shares in issue so a bit of net buying and this anomalous undervaluation will resolve itself imho

[curlly] 14/9/2011 10:44

Seems to be comeing of the bottem since results.
Hope theres more blue to come

[fairdeal2008] 13/9/2011 16:00

Well rob if nothing else at moment you are buying 9p for 3p as Mkt cap is a third of cash with small cash burn per month

[robward] 13/9/2011 12:22

Hi FD
I hope so, took a small position here a few weeks ago !

[maurillac] 13/9/2011 12:05

well i do hope so fd
m

[fairdeal2008] 13/9/2011 11:20

I suspect it's the technology that may be drawing interest. Pharma companies have cash they need ip. Something is brewing here I believe. We will see.

[blue god] 08/9/2011 08:32

Talk that AGI Theraputics may be on the radar of one of the bigger Pharmaceutical Companies.

I guess there $9mln Cash Stash could be tempting, to go along with their technical abilities and ongoing project.

One to watch.

[fairdeal2008] 07/9/2011 13:01

Take a look at the five year chart:

[fairdeal2008] 07/9/2011 10:24

This is totally missed by the Market. Have not seen such an undervaluation for some time - capped at a third of cash at bank it's crazy imho

[marab] 07/9/2011 07:46

Someone could make an offer for the company at twice today's share price and still make a 50% profit, with all the scientific stuff for free. Enough cash for years yet so not a great deal of downside.

[nicd] 07/9/2011 07:24

interims out and still plenty of cash in hand at end June

[lufc5] 07/9/2011 00:48

....and the FD last bought at €0.045 so would he be throwing his cash away likely??.....erm I very much doubt it. Me thinks he knew something back in March of this year.

AGI was informed on 25 March 2011 that David Kelly, a Director and Chief Financial Officer of AGI, purchased 550,000 ordinary shares of €0.01 each ("Ordinary Share") in the share capital of the Company at a price of €0.045 per Ordinary Share on 25 March 2011.

I've added more at sub 3p.

[fairdeal2008] 06/9/2011 14:46

Well I am having fun trying ;-)

[tiltonboy] 06/9/2011 14:44

My concern is that they are only approaching the Proof of Concept stage, and trying to value the company on the back of it's cash is almost meaningless.

[fairdeal2008] 06/9/2011 14:37

As we are valued at just 31% of potential cash at bank, we dont need to venture too far down that debate Tilton. ;-)

I think they have a distinct value here because of the specifics of their ongoing operations but you right, it depends on various factors.

IP we dont know what it is yet, although Orphan Drug applications suggest it could be interesting (fewer sufferers but can be very lucrative per patient for chronic conditions).

imho

[tiltonboy] 06/9/2011 14:33

IP and tax losses can prove to be next to worthless...ask HML.

[christianf12] 06/9/2011 14:31

sounds right!

[fairdeal2008] 06/9/2011 14:30

Well here is my take.

Cash 30.6.10. $10.4mn, cash 31.12.10, $10mn.

Assuming consistent burn cash should be around $9.5mn net of the patent sale, so around £5.9million.

Shares in issue 67 million, so the math: 5.9/67 = 8.8p cash per share. share price 2.75p or 31% of cash, nothing for tax losses and IP.

That is how undervalued agi are... imho (anyone correct me please)

[double6] 06/9/2011 13:15

Director bought at 4.5 (Euro cent) a few weeks back.

[marab] 06/9/2011 13:13

double6 - thanks for the reply. I wondered if perhaps they needed funding for a large scale trial or something. Just bought a few anyway as at this price there doesn't seem to be a lot of downside. Doesn't seem to be any problem in buying so maybe a large(ish?) seller getting out for whatever reason.

[double6] 06/9/2011 13:06

Marab - with $10mln worth of Cash / Deposits, I don't thinking funding is a worry.

Any positive update on the ongoing orphan drugs should see a return to the 5p levels of a few months back.

[marab] 06/9/2011 13:04

That's a serious drop heading in to the results. Normally I would think there was a placing on the way. Any thoughts?

[double6] 06/9/2011 13:00

Oh So Quiet!